Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP953114.RAKXpBkKmzVzyU5eumWxIQYXrZdFp0ayHx1t-eMD_x0_I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP953114.RAKXpBkKmzVzyU5eumWxIQYXrZdFp0ayHx1t-eMD_x0_I130_assertion type Assertion NP953114.RAKXpBkKmzVzyU5eumWxIQYXrZdFp0ayHx1t-eMD_x0_I130_head.
- NP953114.RAKXpBkKmzVzyU5eumWxIQYXrZdFp0ayHx1t-eMD_x0_I130_assertion description "[We assessed changes in the apoptosis-related genes BCL2, BAX, BCL2L12, FAS and CASPASE-3 in OVCAR-3 human ovarian cancer cells and BT-20 human breast cancer cells to provide an insight into the molecular mechanisms involved in the response of these cells to treatment with anticancer drugs and to assess their value as potential biomarkers of chemotherapy response in breast and ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP953114.RAKXpBkKmzVzyU5eumWxIQYXrZdFp0ayHx1t-eMD_x0_I130_provenance.
- NP953114.RAKXpBkKmzVzyU5eumWxIQYXrZdFp0ayHx1t-eMD_x0_I130_assertion evidence source_evidence_literature NP953114.RAKXpBkKmzVzyU5eumWxIQYXrZdFp0ayHx1t-eMD_x0_I130_provenance.
- NP953114.RAKXpBkKmzVzyU5eumWxIQYXrZdFp0ayHx1t-eMD_x0_I130_assertion SIO_000772 18783338 NP953114.RAKXpBkKmzVzyU5eumWxIQYXrZdFp0ayHx1t-eMD_x0_I130_provenance.
- NP953114.RAKXpBkKmzVzyU5eumWxIQYXrZdFp0ayHx1t-eMD_x0_I130_assertion wasDerivedFrom befree-20150227 NP953114.RAKXpBkKmzVzyU5eumWxIQYXrZdFp0ayHx1t-eMD_x0_I130_provenance.
- NP953114.RAKXpBkKmzVzyU5eumWxIQYXrZdFp0ayHx1t-eMD_x0_I130_assertion wasGeneratedBy ECO_0000203 NP953114.RAKXpBkKmzVzyU5eumWxIQYXrZdFp0ayHx1t-eMD_x0_I130_provenance.